[go: up one dir, main page]

NO960653L - Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens - Google Patents

Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens

Info

Publication number
NO960653L
NO960653L NO960653A NO960653A NO960653L NO 960653 L NO960653 L NO 960653L NO 960653 A NO960653 A NO 960653A NO 960653 A NO960653 A NO 960653A NO 960653 L NO960653 L NO 960653L
Authority
NO
Norway
Prior art keywords
progesterone
oral administration
excipient
polyethylene glycol
pharmaceutical agent
Prior art date
Application number
NO960653A
Other languages
English (en)
Other versions
NO960653D0 (no
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO960653L publication Critical patent/NO960653L/no
Publication of NO960653D0 publication Critical patent/NO960653D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Farmasøytisk preparat for oral administrering av progesteron kan passende inneholde en PEG og en ytterligere eksipiens valgt fra gruppen som omfatter en stivelse, en cellulose, pektin og tragant.
NO960653A 1993-08-20 1996-02-19 Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens NO960653D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (2)

Publication Number Publication Date
NO960653L true NO960653L (no) 1996-02-19
NO960653D0 NO960653D0 (no) 1996-02-19

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960653A NO960653D0 (no) 1993-08-20 1996-02-19 Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens

Country Status (17)

Country Link
EP (1) EP0789560A1 (no)
JP (1) JPH09501682A (no)
KR (1) KR960703570A (no)
CN (1) CN1132478A (no)
AU (1) AU7530594A (no)
BR (1) BR9407306A (no)
CA (1) CA2169840A1 (no)
CZ (1) CZ42596A3 (no)
DK (1) DK95093D0 (no)
FI (1) FI960749A0 (no)
HU (1) HUT74167A (no)
LT (1) LT4043B (no)
NO (1) NO960653D0 (no)
NZ (1) NZ271617A (no)
PL (1) PL313113A1 (no)
SK (1) SK19396A3 (no)
WO (1) WO1995005807A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
BR0014159A (pt) * 1999-08-31 2002-05-07 Schering Ag Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768L (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
WO2003077923A1 (en) * 2002-03-14 2003-09-25 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
BRPI0409860A (pt) * 2003-04-29 2006-05-16 Akzo Nobel Nv processo de solidificação anti-solvente
CN101166521A (zh) 2005-04-28 2008-04-23 惠氏公司 通过湿制粒法制备包含微粒化他那普戈特的组合物
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
PL313113A1 (en) 1996-06-10
WO1995005807A1 (en) 1995-03-02
AU7530594A (en) 1995-03-21
DK95093D0 (da) 1993-08-20
CZ42596A3 (en) 1996-06-12
SK19396A3 (en) 1997-03-05
NZ271617A (en) 1996-11-26
KR960703570A (ko) 1996-08-31
CA2169840A1 (en) 1995-03-02
LT96010A (no) 1996-06-25
HU9600376D0 (en) 1996-04-29
HUT74167A (en) 1996-11-28
CN1132478A (zh) 1996-10-02
LT4043B (en) 1996-09-25
JPH09501682A (ja) 1997-02-18
BR9407306A (pt) 1996-10-08
NO960653D0 (no) 1996-02-19
EP0789560A1 (en) 1997-08-20
FI960749L (fi) 1996-02-19
FI960749A0 (fi) 1996-02-19

Similar Documents

Publication Publication Date Title
NO960653L (no) Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens
TR199800902T2 (xx) Ecza form�lasyonlar�.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
NO934500L (no) Ikke-klorfluorcarbonaerosolformuleringer
ATE153853T1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
IL108873A0 (en) 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
ATE185562T1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
HUT77931A (hu) Legalább egy glükokortikoszteroidot és valamely tüdőfelületaktívanyagot tartalmazó, IRDS és ARDS kezelésére szolgáló készítmény
NO942834D0 (no) 1-benzensulfonyl-1,3-dihydro-indol-2-on-derivater, fremstilling derav, og farmasöytiske blandinger som inneholder dem
NO942316D0 (no) Isatinderivater, fremgangsmåter for deres fremstilling og farmasöytisk preparat omfattende slike derivater
NO20014035L (no) System for oral administrasjon av medikament
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
BR0014312B1 (pt) composição farmacêutica contendo uma combinação farmacêutica compreendendo loteprednol e azelastina, medicamento e seu processo de produção, e uso da referida combinação.
SE9602442D0 (sv) Administration of pharmaceuticals
HUP0203645A3 (en) Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
ATE94764T1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung.
ATE236885T1 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
IT1237429B (it) Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono.
NO20013878D0 (no) (1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme
WO1998014454A3 (en) (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO910186L (no) Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat.